These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15509504)

  • 21. The P140K mutant of human O(6)-methylguanine-DNA-methyltransferase (MGMT) confers resistance in vitro and in vivo to temozolomide in combination with the novel MGMT inactivator O(6)-(4-bromothenyl)guanine.
    Woolford LB; Southgate TD; Margison GP; Milsom MD; Fairbairn LJ
    J Gene Med; 2006 Jan; 8(1):29-34. PubMed ID: 16075413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hematoprotection and enrichment of transduced cells in vivo after gene transfer of MGMT(P140K) into hematopoietic stem cells.
    Jansen M; Sorg UR; Ragg S; Flasshove M; Seeber S; Williams DA; Moritz T
    Cancer Gene Ther; 2002 Sep; 9(9):737-46. PubMed ID: 12189523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow-derived cells exhibiting lung epithelial cell characteristics are enriched in vivo using methylguanine DNA methyltransferase-mediated drug resistance.
    Reese JS; Roth JC; Gerson SL
    Stem Cells; 2008 Mar; 26(3):675-81. PubMed ID: 18192231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hematopoietic stem cell gene therapy of murine protoporphyria by methylguanine-DNA-methyltransferase-mediated in vivo drug selection.
    Richard E; Robert E; Cario-André M; Ged C; Géronimi F; Gerson SL; de Verneuil H; Moreau-Gaudry F
    Gene Ther; 2004 Nov; 11(22):1638-47. PubMed ID: 15284838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitization of pancreatic tumor xenografts to carmustine and temozolomide by inactivation of their O6-Methylguanine-DNA methyltransferase with O6-benzylguanine or O6-benzyl-2'-deoxyguanosine.
    Kokkinakis DM; Ahmed MM; Chendil D; Moschel RC; Pegg AE
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3801-7. PubMed ID: 14506174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retroviral vector-mediated expression of HoxB4 in hematopoietic cells using a novel coexpression strategy.
    Klump H; Schiedlmeier B; Vogt B; Ryan M; Ostertag W; Baum C
    Gene Ther; 2001 May; 8(10):811-7. PubMed ID: 11420646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloablation is not required to select and maintain expression of the drug-resistance gene, mutant MGMT, in primary and secondary recipients.
    Bowman JE; Reese JS; Lingas KT; Gerson SL
    Mol Ther; 2003 Jul; 8(1):42-50. PubMed ID: 12842427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuclear-localizing O6-benzylguanine-resistant GFP-MGMT fusion protein as a novel in vivo selection marker.
    Choi U; DeRavin SS; Yamashita K; Whiting-Theobald N; Linton GF; Loktionova NA; Pegg AE; Malech HL
    Exp Hematol; 2004 Aug; 32(8):709-19. PubMed ID: 15308322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous protection of G156A methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and sensitization of tumor cells using O6-benzylguanine and temozolomide.
    Reese JS; Davis BM; Liu L; Gerson SL
    Clin Cancer Res; 1999 Jan; 5(1):163-9. PubMed ID: 9918215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction in hematopoietic stem cell numbers with in vivo drug selection can be partially abrogated by HOXB4 gene expression.
    Sawai N; Persons DA; Zhou S; Lu T; Sorrentino BP
    Mol Ther; 2003 Sep; 8(3):376-84. PubMed ID: 12946310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo selection of transduced hematopoietic stem cells and little evidence of their conversion into hepatocytes in vivo.
    Yamaguchi K; Itoh K; Masuda T; Umemura A; Baum C; Itoh Y; Okanoue T; Fujita J
    J Hepatol; 2006 Nov; 45(5):681-7. PubMed ID: 16837099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemoprotective gene transfer II: multilineage in vivo protection of haemopoiesis against the effects of an antitumour agent by expression of a mutant human O6-alkylguanine-DNA alkyltransferase.
    Chinnasamy N; Rafferty JA; Hickson I; Lashford LS; Longhurst SJ; Thatcher N; Margison GP; Dexter TM; Fairbairn LJ
    Gene Ther; 1998 Jun; 5(6):842-7. PubMed ID: 9747465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicistronic lentiviral vectors containing the FMDV 2A cleavage factor demonstrate robust expression of encoded genes at limiting MOI.
    Chinnasamy D; Milsom MD; Shaffer J; Neuenfeldt J; Shaaban AF; Margison GP; Fairbairn LJ; Chinnasamy N
    Virol J; 2006 Mar; 3():14. PubMed ID: 16539700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A bicistronic SIN-lentiviral vector containing G156A MGMT allows selection and metabolic correction of hematopoietic protoporphyric cell lines.
    Richard E; Géronimi F; Lalanne M; Ged C; Redonnet-Vernhet I; Lamrissi-Garcia I; Gerson SL; de Verneuil H; Moreau-Gaudry F
    J Gene Med; 2003 Sep; 5(9):737-47. PubMed ID: 12950064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancing hemopoietic drug resistance: a rationale for reconsidering the clinical use of mitozolomide.
    Fairbairn LJ; Chinnasamy N; Lashford LS; Chinnasamy D; Rafferty JA
    Cancer Gene Ther; 2000 Feb; 7(2):233-9. PubMed ID: 10770631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual agent chemoprotection by retroviral co-expression of either MDR1 or MRP1 with the P140K mutant of O6-methylguanine-DNA-methyl transferase.
    Southgate TD; Garside E; Margison GP; Fairbairn LJ
    J Gene Med; 2006 Aug; 8(8):972-9. PubMed ID: 16733832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HOXB4 overexpression mediates very rapid stem cell regeneration and competitive hematopoietic repopulation.
    Antonchuk J; Sauvageau G; Humphries RK
    Exp Hematol; 2001 Sep; 29(9):1125-34. PubMed ID: 11532354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrovirus-mediated expression of a DNA repair protein in bone marrow protects hematopoietic cells from nitrosourea-induced toxicity in vitro and in vivo.
    Moritz T; Mackay W; Glassner BJ; Williams DA; Samson L
    Cancer Res; 1995 Jun; 55(12):2608-14. PubMed ID: 7780976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of 1,3-bis(2-chloroethyl)-1-nitrosourea-induced severe immunodeficiency by transduction of murine long-lived hemopoietic progenitor cells using O6-methylguanine DNA methyltransferase complementary DNA.
    Maze R; Kapur R; Kelley MR; Hansen WK; Oh SY; Williams DA
    J Immunol; 1997 Jan; 158(2):1006-13. PubMed ID: 8993023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of HOXB4 and NUP98-HOXA10hd on hematopoietic repopulating cells in a nonhuman primate model.
    Watts KL; Zhang X; Beard BC; Chiu SY; Trobridge GD; Humphries RK; Kiem HP
    Hum Gene Ther; 2011 Dec; 22(12):1475-82. PubMed ID: 21787196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.